Cheng Andrew, President and CEO of Akero Therapeutics, Inc. ($AKRO), sold shares on the open market 17 times over the last 365 days, totaling $10.7 million. His most recent sale occurred on October 10, 2025. These $AKRO insider sales rank 1,071st among 11,678 individual insiders in our database, above the average sale value of $8.6 million and transaction count of 6.4. Cheng Andrew made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 3527 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 87220 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.11% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 165289 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.20% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 23809 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 233252 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.28% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 374985 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.46% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 292179 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.35% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 4739 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Common Stock | 277075 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.34% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Common Stock | 159762 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.19% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 3421 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 5032 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 2328 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 234000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.28% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | D | Stock Option (Right to Buy) | 238973 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.29% |
| Nov. 20, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | G | Common Stock | 74538 | $0.00 | 436,837.0000 | 82,316,179 | 14.58% | 0.09% |
| Nov. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | G | Common Stock | 14739 | $0.00 | 511,375.0000 | 82,316,179 | 2.80% | 0.02% |
| Oct. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 30000 | $0.00 | 380,017.0000 | 79,620,128 | 7.32% | 0.04% |
| Oct. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 30000 | $53.98 | 526,114.0000 | 79,620,128 | 5.39% | 0.04% |
| Oct. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 30000 | $19.87 | 556,114.0000 | 79,620,128 | 5.70% | 0.04% |
| Oct. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 52212 | $0.62 | 526,114.0000 | 79,620,128 | 11.02% | 0.07% |
| Oct. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 52212 | $0.00 | 0.0000 | 79,620,128 | 100.00% | 0.07% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 13022 | $6.36 | 503,779.0000 | 79,620,128 | 2.65% | 0.02% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 1919 | $0.00 | 410,017.0000 | 79,620,128 | 0.47% | 0.00% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 13022 | $0.00 | 0.0000 | 79,620,128 | 100.00% | 0.02% |
| Sept. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 1796 | $43.02 | 473,902.0000 | 79,620,128 | 0.38% | 0.00% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 158 | $44.62 | 475,698.0000 | 79,620,128 | 0.03% | 0.00% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7317 | $44.00 | 475,856.0000 | 79,620,128 | 1.51% | 0.01% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 22525 | $42.99 | 483,173.0000 | 79,620,128 | 4.45% | 0.03% |
| Sept. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 1919 | $19.87 | 505,698.0000 | 79,620,128 | 0.38% | 0.00% |
| Aug. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 10795 | $48.07 | 509,962.0000 | 79,620,128 | 2.07% | 0.01% |
| Aug. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 400 | $49.44 | 490,757.0000 | 79,620,128 | 0.08% | 0.00% |
| Aug. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 18805 | $48.87 | 491,157.0000 | 79,620,128 | 3.69% | 0.02% |
| July 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 15314 | $51.73 | 520,757.0000 | 79,620,128 | 2.86% | 0.02% |
| July 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 14686 | $50.57 | 536,071.0000 | 79,620,128 | 2.67% | 0.02% |
| June 30, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | A | Common Stock | 890 | $23.87 | 550,757.0000 | 79,620,128 | 0.16% | 0.00% |
| June 18, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 6620 | $54.84 | 549,867.0000 | 79,620,128 | 1.19% | 0.01% |
| June 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7837 | $53.99 | 556,487.0000 | 79,620,128 | 1.39% | 0.01% |
| June 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 15158 | $54.35 | 564,324.0000 | 79,620,128 | 2.62% | 0.02% |
| June 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 14842 | $53.76 | 579,482.0000 | 79,620,128 | 2.50% | 0.02% |
| May 14, 2025 | Vera Therapeutics, Inc. | $VERA | Cheng Andrew | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 63,748,290 | 9999.99% | 0.02% |
| May 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 22800 | $41.63 | 594,324.0000 | 79,620,128 | 3.69% | 0.03% |
| May 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7200 | $41.00 | 617,124.0000 | 79,620,128 | 1.15% | 0.01% |
| April 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 30000 | $35.23 | 624,324.0000 | 79,620,128 | 4.58% | 0.04% |
| March 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 1738 | $44.88 | 654,324.0000 | 79,620,128 | 0.26% | 0.00% |
| March 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 1216 | $42.31 | 656,062.0000 | 79,620,128 | 0.19% | 0.00% |
| March 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 28784 | $41.75 | 657,278.0000 | 79,620,128 | 4.20% | 0.04% |
| Feb. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 749 | $54.55 | 686,262.0000 | 0 | 0.11% | 0.00% |
| Feb. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 12640 | $51.75 | 703,422.0000 | 0 | 1.77% | 0.00% |
| Feb. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 6439 | $52.91 | 696,983.0000 | 0 | 0.92% | 0.00% |
| Feb. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 9972 | $53.67 | 687,011.0000 | 0 | 1.43% | 0.00% |
| Feb. 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 200 | $55.81 | 686,062.0000 | 0 | 0.03% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 3377 | $56.89 | 716,062.0000 | 0 | 0.47% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 24242 | $54.56 | 721,820.0000 | 0 | 3.25% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 2381 | $55.53 | 719,439.0000 | 0 | 0.33% | 0.00% |
| Jan. 23, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 50000 | $0.62 | 746,062.0000 | 0 | 7.18% | 0.00% |
| Jan. 23, 2025 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 50000 | $0.00 | 52,212.0000 | 0 | 48.92% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | A | Common Stock | 98500 | $0.00 | 696,062.0000 | 0 | 16.48% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | A | Stock Option (Right to Buy) | 295600 | $0.00 | 295,600.0000 | 0 | 9999.99% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7855 | $30.79 | 597,562.0000 | 0 | 1.30% | 0.00% |
| Dec. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 111,029.0000 | 0 | 18.38% | 0.00% |
| Dec. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 25000 | $32.09 | 605,417.0000 | 0 | 3.97% | 0.00% |
| Dec. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 25000 | $21.10 | 630,417.0000 | 0 | 4.13% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 27086 | $21.10 | 632,503.0000 | 0 | 4.47% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 81280 | $21.10 | 686,697.0000 | 0 | 13.43% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 27086 | $0.00 | 136,029.0000 | 0 | 16.61% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 27086 | $32.50 | 605,417.0000 | 0 | 4.28% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 81280 | $0.00 | 163,115.0000 | 0 | 33.26% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 81280 | $31.47 | 605,417.0000 | 0 | 11.84% | 0.00% |
| Oct. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 24992 | $31.14 | 605,417.0000 | 0 | 3.96% | 0.00% |
| Oct. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Righto Buy) | 3103 | $0.00 | 157,248.0000 | 0 | 1.94% | 0.00% |
| Oct. 18, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Righto Buy) | 63539 | $0.00 | 93,709.0000 | 0 | 40.41% | 0.00% |
| Oct. 18, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 226 | $32.12 | 605,417.0000 | 0 | 0.04% | 0.00% |
| Oct. 18, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 63313 | $31.53 | 605,643.0000 | 0 | 9.46% | 0.00% |
| Oct. 18, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 63539 | $21.10 | 668,956.0000 | 0 | 10.50% | 0.00% |
| Oct. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 3103 | $31.12 | 605,417.0000 | 0 | 0.51% | 0.00% |
| Oct. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 3103 | $21.10 | 608,520.0000 | 0 | 0.51% | 0.00% |
| Oct. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Righto Buy) | 24992 | $0.00 | 160,351.0000 | 0 | 13.48% | 0.00% |
| Oct. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 24992 | $21.10 | 630,409.0000 | 0 | 4.13% | 0.00% |
| Sept. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 1738 | $26.18 | 605,417.0000 | 0 | 0.29% | 0.00% |
| Aug. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 24538 | $0.62 | 607,155.0000 | 0 | 4.21% | 0.00% |
| Aug. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 24538 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | A | Common Stock | 1064 | $19.94 | 582,617.0000 | 0 | 0.18% | 0.00% |
| June 11, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7894 | $22.64 | 581,553.0000 | 0 | 1.34% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Cheng Andrew | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| March 13, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 1969 | $28.33 | 589,447.0000 | 0 | 0.33% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 7995 | $35.49 | 591,530.0000 | 0 | 1.33% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 14680 | $34.63 | 599,525.0000 | 0 | 2.39% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 9614 | $33.83 | 614,205.0000 | 0 | 1.54% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 6770 | $32.28 | 623,819.0000 | 0 | 1.07% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 35827 | $31.40 | 630,589.0000 | 0 | 5.38% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 17267 | $21.10 | 666,416.0000 | 0 | 2.66% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 57733 | $16.00 | 649,149.0000 | 0 | 9.76% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 57733 | $0.00 | 10,000.0000 | 0 | 85.24% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 17267 | $0.00 | 244,395.0000 | 0 | 6.60% | 0.00% |
| March 4, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | S | Common Stock | 114 | $36.28 | 591,416.0000 | 0 | 0.02% | 0.00% |
| Jan. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Common Stock | 40000 | $0.62 | 590,911.0000 | 0 | 7.26% | 0.00% |
| Jan. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Cheng Andrew | President and CEO | M | Stock Option (Right to Buy) | 40000 | $0.00 | 24,538.0000 | 0 | 61.98% | 0.00% |
| May 10, 2023 | Vera Therapeutics, Inc. | $VERA | Cheng Andrew | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |